SCHEMBL531436

SCHEMBL531436

CCCCCCCCCCCCCC(=O)NCCC(=O)O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 6/20 0.76
CNR1 P21554 2/20 0.76
CNR2 P34972 2/20 0.76
PLA2G2A P14555 1/20 0.68
EPHX2 P34913 3/20 0.68
DNM1 Q05193 1/20 0.62
KDM4E B2RXH2 1/20 0.62
CASP2 P42575 1/20 0.62
PPARG P37231 4/20 0.61
PPARD Q03181 4/20 0.61
PPARA Q07869 4/20 0.61
TSHR P16473 3/20 0.61
GPR84 Q9NQS5 3/20 0.61
HDAC11 Q96DB2 3/20 0.61
ALDH1A1 P00352 2/20 0.61
TDP1 Q9NUW8 2/20 0.61
SLC22A6 Q4U2R8 1/20 0.61
SLC22A8 Q8TCC7 1/20 0.61
TLR2 O60603 1/20 0.61
MEN1 O00255 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL532448 1.00 FAAH (0.76) FAAHCNR1CNR2PLA2G2AEPHX2
SCHEMBL4000461 1.00 FAAH (0.76) FAAHCNR1CNR2PLA2G2AEPHX2
SCHEMBL9828949 1.00 FAAH (0.76) FAAHCNR1CNR2PLA2G2AEPHX2
SCHEMBL9193102 1.00 FAAH (0.76) FAAHCNR1CNR2PLA2G2AEPHX2
SCHEMBL9256918 1.00 FAAH (0.76) FAAHCNR1CNR2PLA2G2AEPHX2
SCHEMBL3990517 1.00 FAAH (0.76) FAAHCNR1CNR2PLA2G2AEPHX2
SCHEMBL5964111 1.00 FAAH (0.76) FAAHCNR1CNR2PLA2G2AEPHX2
SCHEMBL31529340 1.00 FAAH (0.76) FAAHCNR1CNR2PLA2G2AEPHX2
SCHEMBL7147169 1.00 FAAH (0.76) FAAHCNR1CNR2PLA2G2AEPHX2
SCHEMBL688844 0.98 FAAH (0.73) FAAHCNR1CNR2PLA2G2AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110225743-A Microemulsion compositions comprising polydatin and methods of use 莱雅公司 2019-09-10 CN claimed
CN-103479529-A Surfactant composition and uses thereof SUZHOU YUANSUJI CHEMICAL INDUSTRY CO LTD 2014-01-01 CN claimed
CN-103479532-A Surfactant composition and uses thereof SUZHOU YUANSUJI CHEMICAL INDUSTRY CO LTD 2014-01-01 CN claimed
EP-2376057-A2 CLEANSING COMPOSITION KPSS-Kao Professional Salon Services GmbH (DE) 2011-10-19 EP claimed
US-20110206629-A1 CLEANSING COMPOSITION KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) 2011-08-25 US claimed
US-20110165106-A1 CLEANSING COMPOSITION KPSS-KAO PROFESSIONAL SALON SERVICES GBMH (DE) 2011-07-07 US claimed
US-20110165104-A1 CLEANSING COMPOSITION KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) 2011-07-07 US claimed
WO-2011072855-A1 CLEANSING COMPOSITION KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) 2011-06-23 WO claimed
EP-2335680-A1 Cleansing composition KPSS-Kao Professional Salon Services GmbH (DE) 2011-06-22 EP claimed
EP-2320863-A1 CLEANSING COMPOSITION KPSS-Kao Professional Salon Services GmbH (DE) 2011-05-18 EP claimed
EP-2320862-A1 CLEANSING COMPOSITION KPSS-Kao Professional Salon Services GmbH (DE) 2011-05-18 EP claimed
US-5712232-A ANIONIC SURFACTANT AND A SALT KAO CORPORATION (JP) 1998-01-27 US claimed
US-4749515-A SULFOSUCCINIC ACID MONOESTERS, ACYLATED PEPTIDES; FOAMING, RINSING PROPERTIES LION CORPORATION (JP) 1988-06-07 US claimed
CN-119632854-A Cosmetic composition for skin care 莱雅公司 2025-03-18 CN disclosed
CN-115803004-B Stable composition containing polydatin 莱雅公司 2024-12-06 CN disclosed
CN-118632681-A Composition for cleaning and/or removing makeup from keratin materials 莱雅公司 2024-09-10 CN disclosed
US-5391564-A E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents SANKYO COMPANY, LIMITED (JP) 1995-02-21 US disclosed
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US disclosed
EP-0350315-B1 RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1993-06-16 EP disclosed
EP-0350315-A1 Rhizoxin derivates and their use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1990-01-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110206629-A1 CLEANSING COMPOSITION KRT18, HCN4, KCNH3 FAAH 3307/4885CNR1 2066/4885CNR2 1757/4885
US-20110165106-A1 CLEANSING COMPOSITION KRT18, DSG1, KCNH3 FAAH 2811/4885CNR1 2548/4885CNR2 2463/4885
US-20110165104-A1 CLEANSING COMPOSITION KRT18, DSG1, KCNH3 FAAH 2607/4885CNR1 2456/4885CNR2 2223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.